Theratechnologies (NASDAQ:THTX) Announces Earnings Results, Beats Estimates By $0.04 EPS

Theratechnologies (NASDAQ:THTX) posted its earnings results on Wednesday. The company reported $0.02 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.04, Yahoo Finance reports. The company had revenue of $22.02 million for the quarter. During the same period in the prior year, the company posted ($0.40) EPS. Theratechnologies updated its FY 2024 guidance to EPS.

Theratechnologies Stock Performance

Shares of THTX opened at $1.45 on Friday. The company has a 50 day moving average of $1.30 and a two-hundred day moving average of $1.47. Theratechnologies has a twelve month low of $0.88 and a twelve month high of $3.60.

About Theratechnologies

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.